- Home
- VNRX vs NOTE Comparison
VNRX vs NOTE Comparison
Compare VNRX & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- NOTE
- Stock Information
- Founded
- VNRX N/A
- NOTE 2013
- Country
- VNRX United States
- NOTE United States
- Employees
- VNRX N/A
- NOTE N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NOTE EDP Services
- Sector
- VNRX Health Care
- NOTE Technology
- Exchange
- VNRX Nasdaq
- NOTE Nasdaq
- Market Cap
- VNRX 69.7M
- NOTE 65.4M
- IPO Year
- VNRX N/A
- NOTE N/A
- Fundamental
- Price
- VNRX $0.45
- NOTE $4.26
- Analyst Decision
- VNRX Strong Buy
- NOTE Strong Buy
- Analyst Count
- VNRX 4
- NOTE 4
- Target Price
- VNRX $3.50
- NOTE $29.25
- AVG Volume (30 Days)
- VNRX 712.7K
- NOTE 286.8K
- Earning Date
- VNRX 11-13-2025
- NOTE 11-11-2025
- Dividend Yield
- VNRX N/A
- NOTE N/A
- EPS Growth
- VNRX N/A
- NOTE N/A
- EPS
- VNRX N/A
- NOTE N/A
- Revenue
- VNRX $1,319,252.00
- NOTE $109,683,000.00
- Revenue This Year
- VNRX $324.32
- NOTE N/A
- Revenue Next Year
- VNRX $247.82
- NOTE $41.76
- P/E Ratio
- VNRX N/A
- NOTE N/A
- Revenue Growth
- VNRX 35.10
- NOTE N/A
- 52 Week Low
- VNRX $0.40
- NOTE $3.80
- 52 Week High
- VNRX $0.94
- NOTE $24.36
- Technical
- Relative Strength Index (RSI)
- VNRX 30.37
- NOTE 47.84
- Support Level
- VNRX $0.43
- NOTE $4.45
- Resistance Level
- VNRX $0.52
- NOTE $5.08
- Average True Range (ATR)
- VNRX 0.05
- NOTE 0.38
- MACD
- VNRX -0.02
- NOTE -0.18
- Stochastic Oscillator
- VNRX 7.58
- NOTE 6.25
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.